Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
ASCO
Jun 17, 2024, 13:17 |
Insight
Neeraj Agarwal: Expert guidance on management of AEs in patients with prostate cancer
Neeraj Agarwal shared on X/Twitter: "Just in European Urology Oncology. Expert guidance (by modified Delphi panel…
Jun 17, 2024, 13:10 |
Immune Oncology
Immunotherapy for Pancreatic Cancer
About Pancreatic Cancer Pancreatic cancer is one of the most lethal and aggressive forms of…
Jun 17, 2024, 12:35 |
Blog
Herbert Loong: CTOS24 abstract submission deadline has been extended to June 24
Herbert Loong shared on LinkedIn: "Attention All Sarcoma folks! Connective Tissue Oncology Society. CTOS24 abstract submission…
Jun 17, 2024, 12:11 |
Cancer Types
Stomach cancer: What patients should know about
Introduction, what is stomach cancer Stomach cancer, also known as gastric cancer, is a type…
Jun 17, 2024, 11:39 |
Insight
Bot/bal in relapsed refractory MSS metastatic colorectal cancer - a quick summary
Arndt Vogel shared a post on X: "Botensilimab plus balstilimab in relapsed/refractory MSS mCRC. Phase…
Jun 16, 2024, 19:29 |
Insight
Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
Kristina Jenei, Associate Editor at the Journal of Cancer Policy, shared on X/Twitter: "New original…
Jun 16, 2024, 16:07 |
Blog
Fumiko Ladd Chino: We're going to usher in a new era of multidisciplinary leadership!
Fumiko Ladd Chino shared one of her previous posts on X and added: "Of note,…
Jun 16, 2024, 15:24 |
Positive
Ivy Riano has been honored with Almy Professor’s Award for Excellence in Teaching
Narjust Florez recently shared a post by Ivy Riano, Hematology and Oncology Research Chief Fellow…
Jun 16, 2024, 10:58 |
Blog
Kinjal Shankar Majumdar: Applications for IDEA 2025 opens on 1st July 2024
Kinjal Shankar Majumdar, Visiting Fellow at Healthcare Global Enterprises Limited, shared on LinkedIn "Recently awarded with…
Jun 16, 2024, 09:13 |
Insight
Estela Rodriguez: Subcutaneous vs IV Amivantamab + Lazertinib in NSCLC
Estela Rodriguez shared on X/Twitter: "PALOMA3 Subq (SC) vs IV Amivantamab + Lazertinib, in Refractory EGFR+…
167
168
169
170
171
All:
2825
Posts:
1681 - 1690
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube